PHOENIX--(BUSINESS WIRE)--PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the launch of its new LANCE® Ultra cAMP Detection Kit . Designed for screening and profiling of G-protein coupled receptors (GPCRs) as tools in the search for potential therapeutics, the LANCE® Ultra kit offers three times the sensitivity using at least 80 percent fewer cells than other kits currently on the market.
